4D Molecular Therapeutics Inc

FDMT

David H. Kirn is an American entrepreneur-innovator, physician-scientist, CEO and professor. He is co-founder and CEO of 4D Molecular Therapeutics (4DMT), a biotechnology company designing and developing adeno-associated virus gene therapy vectors.Kirn is the co-founder and board member of the Life …

Insider trades and stock quote 2024-2026

All insider trades at 4D Molecular Therapeutics Inc

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/4/2026 Sell Kirn, David Officer $10.2 $274,596
8/3/2026 Sell Kirn, David Officer $10.0 $124,722
7/10/2026 Sell Kirn, David Officer $12.4 $189,233
7/9/2026 Sell Kirn, David Officer $12.9 $548,177
6/30/2026 Sell Bizily, Scott Chief Legal Officer $14.0 $91,924
6/23/2026 Sell Bizily, Scott Chief Legal Officer $12.0 $117,720
6/22/2026 Sell Kirn, David Officer $10.5 $1,200,851
6/1/2026 Sell Kirn, David Officer $10.0 $19,258
3/20/2026 Sell Gupta, Ashoo VP, Finance and Controller $8.6 $3,358
12/20/2025 Sell Gupta, Ashoo VP, Finance and Controller $8.7 $3,377
12/16/2025 Sell Bizily, Scott Chief Legal Officer $10.9 $17,822
11/17/2025 Sell Bizily, Scott Chief Legal Officer $10.6 $17,315
10/24/2025 Sell Bizily, Scott Chief Legal Officer $12.0 $32,136
10/16/2025 Sell Bizily, Scott Chief Legal Officer $10.2 $16,628
10/9/2025 Sell Bizily, Scott Chief Legal Officer $10.0 $24,080
9/23/2025 Sell Bizily, Scott Chief Legal Officer $8.0 $19,256
9/16/2024 Sell Bizily, Scott Chief Legal Officer $16.3 $8,165
8/19/2024 Sell Bizily, Scott Chief Legal Officer $15.0 $7,500
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)